| NCT04322708 |
A Study of Antolimab (AK002) in Patients With Active Eosinophilic Esophagitis |
https://ClinicalTrials.gov/show/NCT04322708 |
Recruiting |
Allakos, Inc. |
2021-12-31 |
| NCT04322604 |
A Study to Assess AK002 in Eosinophilic Gastritis and/or Eosinophilic Duodenitis (Formerly Referred to as Eosinophilic Gastroenteritis) |
https://ClinicalTrials.gov/show/NCT04322604 |
Recruiting |
Allakos, Inc. |
2021-12-31 |
| NCT03633617 |
Study to Determine the Efficacy and Safety of Dupilumab in Adult and Adolescent Patients With Eosinophilic Esophagitis (EoE) |
https://ClinicalTrials.gov/show/NCT03633617 |
Recruiting |
Regeneron Pharmaceuticals |
2022-04-22 |
| NCT03342391 |
CEGIR 7808: Use of Unsedated Transnasal Esophagoscopy (TNE) to Monitor Dietary Management of Eosinophilic Esophagitis in Children |
https://ClinicalTrials.gov/show/NCT03342391 |
Recruiting |
Children’s Hospital Medical Center, Cincinnati |
2020-07-31 |
| NCT03320369 |
CEGIR 7809: Effect of Elemental Diet on Adult Patients With Eosinophilic Gastroenteritis |
https://ClinicalTrials.gov/show/NCT03320369 |
Recruiting |
Children’s Hospital Medical Center, Cincinnati |
2019-09-01 |
| NCT03305653 |
Use of Esophageal String Test to Understand Symptoms, Inflammation, and Function in Eosinophilic Esophagitis |
https://ClinicalTrials.gov/show/NCT03305653 |
Recruiting |
University of Colorado, Denver |
2020-12-31 |
| NCT03191864 |
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE) |
https://ClinicalTrials.gov/show/NCT03191864 |
Active, not recruiting |
Adare Pharmaceuticals, Inc. |
2019-11-08 |
| NCT03078023 |
Sponge and Eosinophil Peroxidase (EPO) Staining |
https://ClinicalTrials.gov/show/NCT03078023 |
Recruiting |
Mayo Clinic |
2021-03-01 |
| NCT03029091 |
An Open-Label Trial of Losartan Potassium in Participants With Eosinophilic Esophagitis (EoE) |
https://ClinicalTrials.gov/show/NCT03029091 |
Completed |
Children’s Hospital Medical Center, Cincinnati |
2019-07-22 |
| NCT02881372 |
EoE Food Desensitization |
https://ClinicalTrials.gov/show/NCT02881372 |
Recruiting |
The University of Texas Health Science Center, Houston |
2020-05-31 |
| NCT02778867 |
SOFEED: Six Food vs. One Food Eosinophilic Esophagitis Diet Study |
https://ClinicalTrials.gov/show/NCT02778867 |
Completed |
Children’s Hospital Medical Center, Cincinnati |
2019-04-17 |
| NCT02736409 |
An Extension Study to Evaluate Maintenance of Efficacy and Long-term Treatment Effect of Oral Budesonide Suspension (OBS) in Adults and Adolescents With Eosinophilic Esophagitis (EoE) |
https://ClinicalTrials.gov/show/NCT02736409 |
Completed |
Shire |
2019-11-04 |
| NCT02722148 |
Application of a Novel Allergen-Specific Immune Signature Directed Approach to Dietary Elimination Therapy in Patients With Eosinophilic Esophagitis (IDiET) |
https://ClinicalTrials.gov/show/NCT02722148 |
Completed |
University of North Carolina, Chapel Hill |
2018-04-30 |
| NCT02610816 |
Eosinophilic Esophagitis Intervention Trial-1 Food vs. 4 Food Elimination Diet Followed by Swallowed Glucocorticoids |
https://ClinicalTrials.gov/show/NCT02610816 |
Completed |
Children’s Hospital Medical Center, Cincinnati |
2018-05-16 |
| NCT02605837 |
A Study in Adolescents and Adults With Eosinophilic Esophagitis (EoE) Measuring Histologic Response and Determine if Reduction in Dysphagia is Achieved |
https://ClinicalTrials.gov/show/NCT02605837 |
Completed |
Shire |
2019-01-24 |
| NCT02599558 |
Cytosponge and Dietary Therapy in EoE |
https://ClinicalTrials.gov/show/NCT02599558 |
Recruiting |
Mayo Clinic |
2020-12-31 |
| NCT02493335 |
Maintenance of Remission With Budesonide Orodispersible Tablets vs. Placebo in Eosinophilic Esophagitis |
https://ClinicalTrials.gov/show/NCT02493335 |
Active, not recruiting |
Dr. Falk Pharma GmbH |
2018-11-28 |
| NCT02434029 |
Budesonide Orodispersible Tablet vs. Placebo in Active Eosinophilic Esophagitis |
https://ClinicalTrials.gov/show/NCT02434029 |
Completed |
Dr. Falk Pharma GmbH |
2016-08-04 |
| NCT02379052 |
Study of Dupilumab in Adult Participants With Active Eosinophilic Esophagitis (EoE) |
https://ClinicalTrials.gov/show/NCT02379052 |
Completed |
Regeneron Pharmaceuticals |
2017-02-17 |
| NCT02371941 |
Oral Cromolyn Sodium for the Treatment of Eosinophilic Esophagitis |
https://ClinicalTrials.gov/show/NCT02371941 |
Completed |
University of Tennessee |
2017-07-31 |
| NCT02353078 |
The Effect of Sucralfate Slurry in Patients With Eosinophilic Esophagitis |
https://ClinicalTrials.gov/show/NCT02353078 |
Completed |
Mayo Clinic |
2016-12-31 |
| NCT02280616 |
Budesonide Effervescent Tablets vs. Viscous Budesonide Suspension vs. Placebo in Eosinophilic Esophagitis |
https://ClinicalTrials.gov/show/NCT02280616 |
Completed |
Dr. Falk Pharma GmbH |
2013-04-30 |
| NCT02227836 |
Value of Patch Testing in Direct Diet Therapy for Eosinophilic Esophagitis |
https://ClinicalTrials.gov/show/NCT02227836 |
Completed |
Mayo Clinic |
2017-09-30 |
| NCT02204150 |
Study to Image the Esophagus Using the OFDI Capsule |
https://ClinicalTrials.gov/show/NCT02204150 |
Completed |
Massachusetts General Hospital |
2015-07-31 |
| NCT02202590 |
Using Spectrally Encoded Confocal Microscopy (SECM) to Image the Esophagus |
https://ClinicalTrials.gov/show/NCT02202590 |
Active, not recruiting |
Massachusetts General Hospital |
2021-12-31 |
| NCT02125851 |
Comparison of Esophageal Clearance Times of Oral Budesonide Preparations |
https://ClinicalTrials.gov/show/NCT02125851 |
Completed |
Walter Reed National Military Medical Center |
2014-02-28 |
| NCT02098473 |
Dose Ranging Study of RPC4046 in Eosinophilic Esophagitis |
https://ClinicalTrials.gov/show/NCT02098473 |
Completed |
Celgene |
2016-02-17 |
| NCT02038894 |
Comparing Anesthetic Techniques in Children Having Esophagogastroduodenoscopies |
https://ClinicalTrials.gov/show/NCT02038894 |
Completed |
Children’s Hospital Medical Center, Cincinnati |
2013-11-30 |
| NCT02019758 |
Budesonide Versus Fluticasone for Treatment of Eosinophilic Esophagitis |
https://ClinicalTrials.gov/show/NCT02019758 |
Completed |
University of North Carolina, Chapel Hill |
2018-05-31 |
| NCT01999439 |
EoE(Eosinophilic Esophagitis) |
https://ClinicalTrials.gov/show/NCT01999439 |
Completed |
University of Michigan |
2016-04-30 |
| NCT01953575 |
Mucosal Impedance and Eosinophilic Esophagitis |
https://ClinicalTrials.gov/show/NCT01953575 |
Completed |
Mayo Clinic |
2019-06-10 |
| NCT01846962 |
Dietetic Versus Topical Steroids for Pediatric Eosinophilic Esophagitis |
https://ClinicalTrials.gov/show/NCT01846962 |
Completed |
Azienda Policlinico Umberto I |
2013-04-30 |
| NCT01642212 |
OBS in Adolescent and Adults With EOE: A Phase II, Randomized, Double-Blind, Placebo Controlled, Study With an Open Label Extension |
https://ClinicalTrials.gov/show/NCT01642212 |
Completed |
Shire |
2014-10-30 |
| NCT01641913 |
Intestinal Permeability in Response to Treatment in Eosinophilic Esophagitis Patients |
https://ClinicalTrials.gov/show/NCT01641913 |
Completed |
Mayo Clinic |
2014-01-31 |
| NCT01585103 |
Cytosponge Protocol IRB 11-006429 |
https://ClinicalTrials.gov/show/NCT01585103 |
Recruiting |
Mayo Clinic |
2021-09-30 |
| NCT01386112 |
Safety and Tolerability Study of Oral EUR-1100 to Treat Eosinophilic Esophagitis |
https://ClinicalTrials.gov/show/NCT01386112 |
Completed |
Forest Laboratories |
2012-10-31 |
| NCT04281108 |
Efficacy and Safety APT-1011 in Subjects With Eosinophilic Esophagitis (EoE) (FLUTE-2) |
https://ClinicalTrials.gov/show/NCT04281108 |
Recruiting |
Adare Pharmaceuticals, Inc. |
2021-10-31 |
| NCT04149470 |
Proton Pump Inhibitor (PPI) Response in Eosinophilic Esophagitis Assessed by Transnasal Endoscopy (TNE) |
https://ClinicalTrials.gov/show/NCT04149470 |
Recruiting |
University of Colorado, Denver |
2021-12-31 |
| NCT04069429 |
Radiation Dose in Humans From Orally Administered Tc99m-Heparin |
https://ClinicalTrials.gov/show/NCT04069429 |
Recruiting |
University of Utah |
2020-12-31 |
| NCT03245840 |
Continuation Study With Budesonide Oral Suspension (BOS) for Adolescent and Adult Subjects With Eosinophilic Esophagitis (EoE) |
https://ClinicalTrials.gov/show/NCT03245840 |
Active, not recruiting |
Shire |
2021-08-31 |
| NCT03781596 |
EoE RCT Fluticasone and Omeprazole vs Fluticasone Alone |
https://ClinicalTrials.gov/show/NCT03781596 |
Recruiting |
Walter Reed National Military Medical Center |
2020-10-02 |
| NCT03664960 |
An Extension Study of AK002 in Patients With Eosinophilic Gastritis and/or Eosinophilic Gastroenteritis |
https://ClinicalTrials.gov/show/NCT03664960 |
Active, not recruiting |
Allakos, Inc. |
2021-03-31 |
| NCT03657771 |
A Food Additive Removal Diet for Pediatric Eosinophilic Esophagitis |
https://ClinicalTrials.gov/show/NCT03657771 |
Recruiting |
Nemours Children’s Clinic |
2020-09-30 |
| NCT03656380 |
Mepo for EoE Study |
https://ClinicalTrials.gov/show/NCT03656380 |
Recruiting |
University of North Carolina, Chapel Hill |
2020-12-31 |
| NCT03496571 |
A Study of AK002 in Patients With Eosinophilic Gastritis and/or Eosinophilic Gastroenteritis |
https://ClinicalTrials.gov/show/NCT03496571 |
Completed |
Allakos, Inc. |
2019-06-24 |
| NCT03473977 |
Benralizumab for Eosinophilic Gastritis |
https://ClinicalTrials.gov/show/NCT03473977 |
Recruiting |
Children’s Hospital Medical Center, Cincinnati |
2020-03-30 |
| NCT03446118 |
MRI to Assess Fibrosis in Eosinophilic Esophagitis Patients |
https://ClinicalTrials.gov/show/NCT03446118 |
Recruiting |
Mayo Clinic |
2021-01-15 |
| NCT01056783 |
Proof of Concept Study of OC000459 in Eosinophilic Esophagitis |
https://ClinicalTrials.gov/show/NCT01056783 |
Completed |
Oxagen Ltd |
2011-06-30 |
| NCT01040598 |
Identifying Responders to Xolair (Omalizumab) Using Eosinophilic Esophagitis as a Disease Model |
https://ClinicalTrials.gov/show/NCT01040598 |
Completed |
O & O Alpan LLC |
2011-12-31 |
| NCT01022970 |
Efficacy and Safety of QAX576 in Patients With Eosinophilic Esophagitis |
https://ClinicalTrials.gov/show/NCT01022970 |
Completed |
Novartis |
2012-02-29 |
| NCT01016223 |
A Randomized Double Blind Placebo Controlled Study of the Effect of Swallowed Beclomethasone Dipropionate on Inflammatory Markers in Adult Patients With Eosinophilic Esophagitis |
https://ClinicalTrials.gov/show/NCT01016223 |
Completed |
Penn State University |
2012-07-31 |
| NCT00961233 |
Topical Budesonide Treatment for Eosinophilic Esophagitis (EoE) |
https://ClinicalTrials.gov/show/NCT00961233 |
Completed |
University of North Carolina, Chapel Hill |
2011-08-31 |
| NCT00895817 |
Fluticasone Versus Esomeprazole to Treat Eosinophilic Esophagitis |
https://ClinicalTrials.gov/show/NCT00895817 |
Completed |
Walter Reed Army Medical Center |
2010-10-31 |
| NCT00880906 |
Study of the Efficiency of Esophageal Dilation on Patient With Eosinophilic Esophagitis |
https://ClinicalTrials.gov/show/NCT00880906 |
Completed |
Vanderbilt University Medical Center |
2013-12-31 |
| NCT02579876 |
Milk Patch for Eosinophilic Esophagitis |
https://ClinicalTrials.gov/show/NCT02579876 |
Completed |
Children’s Hospital of Philadelphia |
2017-12-20 |
| NCT00762073 |
Dose-Ranging Study of Oral Viscous Budesonide in Pediatrics With Eosinophilic Esophagitis |
https://ClinicalTrials.gov/show/NCT00762073 |
Completed |
Shire |
2010-04-30 |
| NCT00728481 |
The Role Of Gastroesophageal Reflux Disease (GERD) in Eosinophilic Esophagitis |
https://ClinicalTrials.gov/show/NCT00728481 |
Completed |
Mayo Clinic |
2010-12-31 |
| NCT00638456 |
Use of Topical Budesonide in the Treatment of Eosinophilic Esophagitis |
https://ClinicalTrials.gov/show/NCT00638456 |
Completed |
University of California, San Diego |
2009-09-30 |
| NCT00635089 |
Open-Label Extension Study of Reslizumab in Pediatric Subjects With Eosinophilic Esophagitis |
https://ClinicalTrials.gov/show/NCT00635089 |
Completed |
Teva Pharmaceutical Industries |
2012-01-31 |
| NCT00538434 |
Efficacy and Safety Study of Reslizumab to Treat Eosinophilic Esophagitis in Subjects Aged 5 to 18 Years |
https://ClinicalTrials.gov/show/NCT00538434 |
Completed |
Teva Pharmaceutical Industries |
2009-10-31 |
| NCT00523354 |
Off Label Use of Infliximab in Adult Patients With Severe Eosinophilic Esophagitis |
https://ClinicalTrials.gov/show/NCT00523354 |
Completed |
Swiss EE Study Group |
2007-09-30 |
| NCT00511316 |
Trial of Montelukast in Eosinophilic Esophagitis |
https://ClinicalTrials.gov/show/NCT00511316 |
Completed |
Mayo Clinic |
2015-09-30 |
| NCT00426283 |
A Study of Flovent in Patients With Eosinophilic Esophagitis |
https://ClinicalTrials.gov/show/NCT00426283 |
Completed |
Children’s Hospital Medical Center, Cincinnati |
2013-01-31 |
| NCT00358449 |
Intravenous Mepolizumab In Children With Eosinophilic Esophagitis |
https://ClinicalTrials.gov/show/NCT00358449 |
Completed |
GlaxoSmithKline |
2008-11-25 |
| NCT00275561 |
Topical Steroid Treatment for Eosinophilic Esophagitis |
https://ClinicalTrials.gov/show/NCT00275561 |
Completed |
Mayo Clinic |
2010-04-30 |
| NCT00274703 |
An Evaluation Of Mepolizumab In Therapy Of Eosinophilic Oesophagitis In Adult Patients |
https://ClinicalTrials.gov/show/NCT00274703 |
Completed |
GlaxoSmithKline |
2007-03-31 |
| NCT00271349 |
Budesonide for Eosinophilic Esophagitis |
https://ClinicalTrials.gov/show/NCT00271349 |
Completed |
Swiss EE Study Group |
2008-07-31 |
| NCT00266578 |
A Study Comparing Swallowed Flovent and Placebo in Patients With Eosinophilic Disorders |
https://ClinicalTrials.gov/show/NCT00266578 |
Completed |
Children’s Hospital Medical Center, Cincinnati |
2006-11-30 |
| NCT00266565 |
Anti-Interleukin-5 (IL-5) Study for Hypereosinophilic Syndrome |
https://ClinicalTrials.gov/show/NCT00266565 |
Completed |
Children’s Hospital Medical Center, Cincinnati |
2012-07-31 |
| NCT00148603 |
Montelukast in the Treatment of Duodenal Eosinophilia |
https://ClinicalTrials.gov/show/NCT00148603 |
Completed |
Children’s Mercy Hospital Kansas City |
NA |
| NCT00123656 |
Comparison of Esomeprazole to Aerosolized, Swallowed Fluticasone for Eosinophilic Esophagitis |
https://ClinicalTrials.gov/show/NCT00123656 |
Completed |
University of Utah |
2006-12-31 |
| NCT00123630 |
A Pilot Study of the Treatment of Eosinophilic Esophagitis With Omalizumab |
https://ClinicalTrials.gov/show/NCT00123630 |
Completed |
University of Utah |
2010-01-31 |
| NCT00084097 |
Omalizumab to Treat Eosinophilic Gastroenteritis |
https://ClinicalTrials.gov/show/NCT00084097 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |